Patent №
US 11,830,615
Granted
2023-11-28
Filed 2019
Owner
OTSUKA PHARMACEUTICAL CO., LTD.
+2 more
Lab
—
AI components
2
kr · planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
16518164
A risk management system (RMS) device includes a RMS database and a RMS processor. The RMS processor includes a prescriber module to receive a request to enroll a patient in a RMS program of a therapeutic agent associated with multiple indications. The request includes a specification of at least one indication, and a confirmation of a diagnostic test conducted on the patient. The RMS processor also includes a patient module configured to generate a patient profile. The RMS processor also includes a database module configured to store the patient profile in the RMS database. The RMS processor also includes an authorization module configured to generate an authorization code indicating whether the patient is authorized to receive the therapeutic agent. The RMS processor also includes a communication module configured to transmit the authorization code to a pharmacy or a prescriber.
AI classification
Ownership
OTSUKA PHARMACEUTICAL CO., LTD.
assignment · 587440793
OTSUKA AMERICA PHARMACEUTICAL, INC.
assignment · 587440884
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
assignment · 587450086